Baseimmune

About Baseimmune

Baseimmune is pioneering the next generation of active immunotherapies by combining cutting-edge computational design with advanced protein engineering. Their platform creates bespoke antigens to address the complexity of chronic diseases, aiming to transform patient outcomes through science-first innovation.

Products & Services

Active Immunotherapies:A platform that designs bespoke antigens to tackle chronic diseases using computational design and protein engineering.

Specialties

Computational Design Protein Engineering Immunotherapy Antigen Development

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 11300000 MR: - FA: 11.3 million FAN: 11300000	D: 2024-02-26 FD: 2024-02-26	6 investors

Series A Latest

2024-02-26

$11.3M

6 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

K

Kevin Walton

CEO

J

Joshua Blight

Co-founder, CSO

P

Phillip Kemlo

Co-founder, VP

R

Rebecca Pike

Interim Head of Operations

E

Eleanor Poulter

Head of Computation

H

Hussein Kanji

Board Director

View 5 more team members with Pro

Unlock Full Team Directory

Recent News

Baseimmune Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised